Frequency of depression, anxiety, and fatıgue in fmf patients and their association with disease parameters

The aim of our study was to assess the levels of depression, anxiety, and fatigue in patients diagnosed with FMF (Familial Mediterranean Fever) and to examine their associations with drug compliance, attack, and being employed or not. Patients presenting to our rheumatology outpatient clinic Tel-Hashomer Classification Criteria were included in the study. Fifty-two diagnosed patients followed up in our rheumatology outpatient clinic (35 female, 17 male), and 30 healthy control subjects whose ages and genders match consisting of the accompanists and visitors of the patients (25 female, 5 male) were included. Risk for depression and anxiety was assessed with HADS (Hospital Anxiety and Depression Scale). Depression and anxiety were observed to be significantly more common in the patients with FMF compared to the healthy controls in this study. Also, the frequency of FMF attacks was found to be associated with depression, anxiety, and fatigue and that regular use of colchicine decreased fatigue. In the light of all these results, the mood should definitely be evaluated during the routine practice in case of a chronic disease such as FMF having a younger patient population compared to other rheumatic diseases, and, if needed, psychiatric support should be received. Also, it should be explained to the patients that the regular use of colchicine would be beneficial for both the disease and fatigue. There is a need for follow-up studies with large case series in order to support the results we obtained.

___

Firestein GS, Budd R, Gabriel SE, et al. Kelley’s textbook of rheumatology. Elsevier Health Sciences, 2012, Philadelphia.

Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial mediterranean fever. Arthr Rheum. 1997;10:1879-85.

Consortium TIF. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial mediterranean Fever. Cell. 1997;90:797-807.

Consortium FF. A candidate gene for familial mediterranean Fever. Nat Genet. 1997;171:25-31.

Chae J, Wood G, Masters S, et al. The B30.2 domain of pyrin, the Familial Mediterranean Fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci. 2006; 103:9982-7.

Livneh A, Langevitz P. Diagnostic and treatment concerns in familial mediterranean fever. Baillieres Best Pract Res Clin Rheumatol. 2000;14:47798.

Isik A, Koca SS, Ozturk A, et al. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26:872-8.

Hanly JG, Fisk JD, McCurdy G, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2005;32:1459-66.

Martindale J, Smith J, Sutton CJ, et al. Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford). 2006;45:1288-93.

Ozen S.New interest in an old disease: Familial Mediterranean Fever. Clin Exp Rheumatol. 1999;17:745-9.

Aydemir Ö, Güvenir T, Küey L, ve ark. Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlik Güvenilirlik Çalışması. Türk Psikiyatri Dergisi. 1997;8:280-7.

Gencay-Can A, Can SS. Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatol Int. 2012;32(1):27-31.

Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58:445-52.

Von Känel R, Hepp U, Kraemer B, et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res. 2007;41:744-52.

Bagci S, Toy B, Tuzun A, et al. Continuity of cytokine activation in patients with Familial Mediterranean Fever. Clin Rheumatol. 2004;23:333-7.

Simsek I, Pay S, Pekel A, et al. Serum proinflammatory cytokines directing T helper 1 polarization in patients with Familial Mediterranean Fever. Rheumatol Int. 2007;27:807-11.

Haznedaroglu S, Ozturk MA, Sancak B, et al. Serum interleukin 17 and interleukin 18 levels in Familial Mediterranean Fever. Clin Exp Rheumatol. 2007;23:77-80.

Erken E, Ozer HT, Gunesacar R. Plasma interleukin-10 and interleukin-12 levels in patients with Familial Mediterranean Fever. Rheumatol Int. 2006;26:862-4.

Duruoz MT, Unal C, Bingul DK, et al. Fatigue in Familial Mediterranean Fever and its relations with other clinical parameters. Rheumatology International. 2018;38:75-81.

Ozcakar L, Onat AM, Kaymak SU, et al. Selective serotonin reuptake inhibitors in Familial Mediterranean Fever: are we treating depression or inflammation? Rheumatol Int. 2005;25:319-20.

Onat AM, Oztürk MA, Ozçakar L, et al. Selective serotonin reuptake inhibitors reduce the attack frequency in Familial Mediterranean Fever. Tohoku J Exp Med. 2007;211:9-14.

Onat AM, Ozçakar L, Oztürk MA, et al. Plasma and platelet serotonin levels in Familial Mediterranean Fever. Clin Exp Rheumatol. 2007;25:16-20.

Deger SM, Ozturk MA, Demirag MD, et al. Health-related quality of life and its associations with mood condition in Familial Mediterranean Fever patients. Rheumatol Int. 2011;31(5):623-8.

Sahin S, Yalcin I, Senel S, et al. Assessment life quality of Familial Mediterranean Fever patients by short form-36 and its relationship with disease parameters. Eur Rev Med Pharmacol Sci. 2013;17:958-63.

Giese A, Kurucay M, Kilic L, et al. Quality of life in adult patients with Familial Mediterranean Fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence. Rheumatol Int. 2013;33:1713-9.

Giese A, Ornek A, Kilic L, et al. Anxiety and depression in adult patients with Familial Mediterranean Fever: a study comparing patients living in Germany and Turkey. Int J Rheum Dis. 2014;1756-185x.12297.

Kucuksahin O, Omma A, Ozdemirel AE, et al. Incidence of sleep disturbances in patients with Familial Mediterranean Fever and the relation of sleep quality with disease activity. Int J Rheum Dis. 2017.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )
Sayıdaki Diğer Makaleler

A study of compulsive buying disorder comorbidity in psychiatric outpatients attending a foundation university outpatient clinic

BARIŞ ÖNEN ÜNSALVER, Sedef KOÇ, ALPER EVRENSEL

Anesthesia management in cesarean section with lown ganong levine syndrome

Duygu DEMİRÖZ ASLAN, Füsun ADAM, Neslihan ALTUNKAYA

Investigation of the efficacy of a novel topical hemostatic agent: Experimental rat study

Ismail ALTİNTOP, Mehmet TATLI

Diffusion-weighted magnetic resonance imaging of thorax in diagnosis of pulmonary embolism

Sevgi YUMRUTEPE, MUHAMMET GÖKHAN TURTAY, Hakan OĞUZTÜRK, ZEYNEP AYFER AYTEMUR, Taner GÜVEN, KASIM TURGUT, ALİ GÜR

Effects of perineural administration of phenytoin in combination with levobupivacaine in a rat sciatic nerve block

AHMET SELİM ÖZKAN, SEDAT AKBAŞ, MEHMET AKİF DURAK, MEHMET ALİ ERDOĞAN, HAKAN PARLAKPINAR, HAKAN PARLAKPINAR, NİGAR VARDI, Onurhal ÖZHAN, ALİ ÖZER

Stroke as fatal complication of ovarian hyperstimulation syndrome

Mohammed Talaat RASHİD, Ahmed KOHAİL

The use of serum hypoxia-inducible factor two alpha levels and diagnostic values in adult carbon monoxide poisoning

Ismail ALTİNTOP, Mehmet TATLI, Çiğdem KARAKÜKCÜ, AHMET ÖZTÜRK

Disseminated hydatid disease treated with albendazole: 15-year experience

Sinem GÜNGÖR, Murat YALÇINSOY, Olga AKKAN, Bülent ALTINSOY, Zeynep Ferhan ÖZŞEKER, Aysun MISIRLIOĞLU, Semra Batı KUTLU, SİBEL ARINÇ, Hatice TÜRKER, Esen AKKAYA

Efficiency of high intensity laser therapy in patients with knee osteoarthritis

Ezgi Deniz ÇIPLAK, SEMRA AKTÜRK, RAİKAN BÜYÜKAVCI, YÜKSEL ERSOY

Perinatal neurological results of patients ailing from advanced eclampsia and preeclampsia: A retrospective study

AYKAN GÜLLEROĞLU, MELİKE KORKMAZ TOKER, Ayşe Gül KARABAY, İlhan GÜney BİÇER, Mustafa Tayfun ALDEMİR